Can a tapeworm drug protect high risk kidney patients from Covid-19? 22 February 2021 We are helping to fund PROTECT-V, a clinical trial to find out if the drug niclosamide, usually used to treat tapeworms, can prevent Covid-19 infection in vulnerable, high risk kidney patients and reduce the number of people who become seriously ill or die from it.  If the trial is successful, it may pave the way for a new…

Read More